Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

J App Pharm Sci. 2021; 11(9): 149-157


The promising role of oleanolic acid in the management of diabetes mellitus: A review

Sasmita Dash, Gurudutta Pattnaik, Nityananda Sahoo, Biswakanth Kar.




Abstract
Cited by 2 Articles

Oleanolic acid (OA) is a bioactive constituent and natural triterpenoid with a pentacyclic structure. OA possesses beneficial effects against diabetes and other metabolic disorder by undergoing a more complex and multifactorial pathway. It activates the insulin response, protects the capability and existence of pancreatic β-cells and also gives protection against diabetic difficulties. The molecular mechanism of antidiabetic activities of OA involve modulation of transduction mechanisms includes oxidative stress-induced hepatic insulin resistance, phosphorylation of extracellular signal-related kinase, protective effect on mitochondrial function, regulates NF-kappa B, suppresses polyol mechanism, formation of advanced glycation end products, activation of M3 muscarinic receptors, and activation of G proteincoupled bile acid receptor.. Thus, the utilization of effective drug or food material carrying OA might be an effective way to control diabetes. Till now, limited clinical studies have been performed to explore the use of OA in the management of diabetes mellitus. However, due to their potential therapeutic activities, OA deserves special attention. In this present review article, we have summarized the antidiabetic potential of OA reported mainly from the period of 2015–2020 with a notable emphasis on the molecular mechanisms. We have searched Google Scholar, medical databases, and websites using related keywords like OA, insulin, diabetes mellitus, herbal medicine, or a combination of them. To qualify for inclusion, the herbal plants should have tremendous antidiabetic activities, established with biomarkers with limited adverse effects.

Key words: Type-II diabetes, pancreatic β-cell, Insulin, Oleanolic acid, bioactive compound






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.